EV/EBITDA
-5.87
+0.16+2.65%
Fri, 21 Feb 2025 22:22:55 GMT
Summary
- As of February 24, 2025, ESLA EV/EBITDA is -5.87, with a rise of +0.16 (+2.65%) during the most recent trading day.
- Over the past year, ESLA EV/EBITDA has dropped by -2.40 (-69.16%).
- ESLA EV/EBITDA is now -243.27% below its all-time high of -1.71.
Performance
ESLA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ESLA EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +2.6% | -2.7% | -2.6% |
1 m1 month | -34.9% | +34.9% | +33.3% |
3 m3 months | -70.1% | +70.2% | +66.3% |
6 m6 months | +4.2% | +15.4% | +9.6% |
ytdytd | -24.4% | +24.3% | +23.3% |
1 y1 year | -69.2% | +78.3% | +42.3% |
5 y5 years | - | - | - |
ESLA EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -40.1% | -6.03 | +2.6% | |
3 m | 3-month | -3.45 | -70.1% | -6.03 | +2.6% |
6 m | 6-month | -2.73 | -115.0% | -6.13 | +4.2% |
1 y | 1-year | -2.73 | -115.0% | -9.95 | +41.0% |
3 y | 3-year | -1.71 | -243.3% | -9.95 | +41.0% |
5 y | 5-year | -1.71 | -243.3% | -9.95 | +41.0% |
alltime | all time | -1.71 | -243.3% | -9.95 | +41.0% |
Estrella Immunopharma EV/EBITDA History
Date | Value |
---|---|
2025 | -5.87(+24.4%) |
Date | Value |
---|---|
2024 | -4.72(+31.5%) |
2023 | -3.59 |
FAQ
- What is Estrella Immunopharma EV/EBITDA?
- What is the all time high EV/EBITDA for Estrella Immunopharma?
- What is ESLA EV/EBITDA year-to-date change?
- What is Estrella Immunopharma EV/EBITDA year-on-year change?
What is Estrella Immunopharma EV/EBITDA?
The current EV/EBITDA of ESLA is -5.87
What is the all time high EV/EBITDA for Estrella Immunopharma?
Estrella Immunopharma all-time high EV/EBITDA is -1.71
What is ESLA EV/EBITDA year-to-date change?
Estrella Immunopharma EV/EBITDA has changed by -1.15 (-24.36%) since the beginning of the year
What is Estrella Immunopharma EV/EBITDA year-on-year change?
Over the past year, ESLA EV/EBITDA has changed by -2.40 (-69.16%)